MARKET

TENX

TENX

Tenax Therapeut
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9180
+0.0153
+1.69%
Closed 19:59 07/06 EDT
OPEN
0.9600
PREV CLOSE
0.9027
HIGH
0.9600
LOW
0.9027
VOLUME
153.72K
TURNOVER
--
52 WEEK HIGH
2.680
52 WEEK LOW
0.2500
MARKET CAP
8.46M
P/E (TTM)
-0.6557
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TENX stock price target is 5.48 with a high estimate of 6.50 and a low estimate of 4.450.

EPS

TENX News

More
Company News for June 3, 2020
Zacks · 06/03 14:41
Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Business Wire · 06/03 13:30
RGA, ARCE among premarket losers
Seeking Alpha - Article · 06/03 13:12
Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Tenax Therapeutics, Inc. (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need,
Benzinga · 06/03 12:35
Ziyad Binsalamah Dissolves Share Stake In Tenax Therapeutics As Of June 2
Benzinga · 06/02 20:22
Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Kaleido Biosciences Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 0.61% to 25630.00 while the NASDAQ rose 0.11% to 9562.43. The S&P also rose, gaining 0.39% to 3067.67.
Benzinga · 06/02 18:30
What's Driving Shares of Nano-Cap Pharma Tenax Higher?
Shares of nano-cap Tenax Therapeutics Inc (NASDAQ: TENX), are advancing strongly Tuesday in the wake of a positive clinical readout.
Benzinga · 06/02 17:07
MGI, WWR, NNA and ADRO among midday movers
Seeking Alpha - Article · 06/02 16:46

Industry

Biotechnology & Medical Research
+0.67%
Pharmaceuticals & Medical Research
+0.72%

Hot Stocks

Symbol
Price
%Change

About TENX

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
More

Webull offers kinds of Tenax Therapeutics Inc stock information, including NASDAQ:TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TENX stock methods without spending real money on the virtual paper trading platform.